Medical/Pharmaceuticals

GSK Advocates Importance of Adult Immunisation amongst Malaysians

KUALA LUMPUR, Malaysia, April 25, 2024 /PRNewswire/ -- As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ensuring that individuals receive necessary vaccinations, adults can remain active, be healthy participants ...

2024-04-25 14:53 1

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptidesfor drug discoveryagainst oncology target selected by Ono TOKYO, April 25, 2024 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery ...

2024-04-25 14:00 396

United Imaging Healthcare Strengthens Partnership with MedikaBazaar for Indian Market Leadership

COLOMBO, Sri Lanka, April 25, 2024 /PRNewswire/ -- United Imaging, a global leader in healthcare innovations, recently hosted a meeting with MedikaBazaar in Colombo, Sri Lanka, to strategically reinforce their partnership. With a robust four-year collaboration resulting in over 300 installations a...

2024-04-25 12:14 554

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, April 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2024-04-25 10:02 749

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

SUZHOU, China and ROCKVILLE, Md., April 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the co...

2024-04-25 09:02 683

Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting

Topline results from Dizal's global pivotal phase II WU-KONG1 Part B study of sunvozertinib will be showcased in a featured oral presentation at the conference. SHANGHAI, April 24, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new med...

2024-04-24 22:10 875

Future Health highlights greater access to treatment for Mental Health Month

SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- A recent poll has highlighted an alarming trend: a staggering 90% of Americans feel we are in a mental health crisis. While Mental Health Month in May seeks to build ...

2024-04-24 22:00 678

Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results

YANGZHOU, China, April 24, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today reported its financial ...

2024-04-24 19:00 950

Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023

* Consolidated revenues up to €273.2 million (+6.5%), EBITDA stands at  €41.7 million (+24.5%); EBIT up to €13.4 million and net profit up to €6.2 million. * Sales increased in all business lines, especially in the ultrasound segment (+9.7%). Second consecutive record sales year for MRI (+3.3%...

2024-04-24 18:00 905

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved inEurope Conditional marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, April 24, 2024 /PR...

2024-04-24 15:00 1102

Samsung Biologics Reports First Quarter 2024 Financial Results

* Recorded Q1'24 consolidated revenue of KRW 946.9 billion * Recorded Q1'24 consolidated operating profit of KRW 221.3 billion * Sustained growth driven by ongoing strategic expansion in capacity and portfolio INCHEON, South Korea, April 24, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 20794...

2024-04-24 14:45 829

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

-       The choice is the individual's hand to treat oneself with love and care, where judgments and negative opinions have no place in personal beauty journeys. KUALA LUMPUR, Malaysia, April 24, 2024 /PRNewswire/ -- RELIFE, the dermatology and aesthetic medicine division of A. Menarini, a wholl...

2024-04-24 10:00 984

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- Hanmi Pharmaceutical (KOSPI: 128940, CEO:Jae...

2024-04-24 09:27 757

Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution

Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today revealed details about itsAdvanced Inta...

2024-04-23 20:00 908

Zayed Sustainability Prize's Beyond2020 Initiative Deploys Life-saving Digital Mammograms in Costa Rica

AI-powered mammography services will help detect breast cancer cases among women living in underprivileged communities acrossCosta Rica ABU DHABI, UAE, April 23, 2024 /PRNewswire/ -- Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for su...

2024-04-23 18:39 896

OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market

SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech firm with a pipeline of immuno-oncology drug candidates, to share technology and clinical ...

2024-04-23 18:37 1166

Smartee Showcases Mandibular Repositioning Technology at IDEM Singapore 2024

SINGAPORE, April 23, 2024 /PRNewswire/ -- Smartee Denti-Technology, a global leader in digital orthodontic solutions, proudly announces its successful participation in the International Dental Exhibition and Meeting (IDEM) 2024, held fromApril 19 to April 21 at Marina Bay Sands, Singapore. &...

2024-04-23 16:51 1182

Borsch Med Introduces Chondroitin Supplements to Singapore for Healthy Joints

Chondroitin-based supplements from Zeria Pharmaceutical launched to promote an active lifestyle SINGAPORE, April 23, 2024 /PRNewswire/ -- Borsch Med Pte Ltd (BM), a leading Traditional Chinese Medicine (TCM), Health and Nutrition company based in Singapore, operated and managed by professionals i...

2024-04-23 15:00 976

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)

SAN DIEGO and WUHAN, China, April 23, 2024 /PRNewswire/ -- HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the N...

2024-04-23 14:54 847

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

* Vertex obtains an exclusive license to TreeFrog's C-StemTM  manufacturing technology in type 1 diabetes  * TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells  BOSTON and BORDEAUX, France, April 23, 2024 /PRNewswire/ -- Vertex Pha...

2024-04-23 12:45 1061
12345 ... 576